CURE PHARMACEUTICAL
CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), one of the most advanced oral thin films on the market today. CURE is developing an array of products in cutting-edge deli... very platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel, and Germany, among other markets. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.
CURE PHARMACEUTICAL
Industry:
Biotechnology Cannabis Manufacturing Pharmaceutical
Founded:
2011-07-01
Address:
Oxnard, California, United States
Country:
United States
Website Url:
http://www.curepharmaceutical.com
Total Employee:
11+
Status:
Active
Contact:
1(805)824-0410
Email Addresses:
[email protected]
Total Funding:
29.04 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-07-28 | Sera Labs | Sera Labs acquired by Cure Pharmaceutical | 20 M USD |
| 2019-05-14 | Chemistry Holdings | Chemistry Holdings acquired by Cure Pharmaceutical | N/A |
Official Site Inspections
http://www.curepharmaceutical.com Semrush global rank: 10.15 M Semrush visits lastest month: 37
- Host name: host244.hostmonster.com
- IP address: 74.220.215.244
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Cure Pharmaceutical"
Our Team - Cure - Cure - Pharmaceutical
Improving lives by redefining how medicines are delivered and experienced. Call our office +(1) (805) 824 0410. Send a message [email protected]See details»
Cure Pharmaceutical - Crunchbase Company Profile
CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems.See details»
CURE Pharmaceutical - LinkedIn
CURE Pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and ...See details»
CURE Pharmaceutical - Craft
Oct 29, 2024 CURE Pharmaceutical has 1 employees at their 1 location and $4.35 m in annual revenue in FY 2023. See insights on CURE Pharmaceutical including office locations, …See details»
CURE Pharmaceutical Provided Full Corporate Update on Recent ...
OXNARD, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR) (“CURE”), a proprietary platform technology company, today announced that …See details»
Robert Davidson - Cure
Robert Davidson is CURE’s CEO and creator of the technology. Prior to his role at CURE, he was President and CEO of InnoZen Inc., CEO of Gel Tech LLC and CEO of Bio Delivery …See details»
CURE Pharmaceutical Unveils Exciting New Brand Identity with …
Jan 17, 2023 CURE Pharmaceutical Holding Corp. (OTCQB:CURR) ("CURE" or the "Company"), a proprietary broad platform and wellness technology company, today …See details»
CURE Pharmaceutical Announces Promotions and Additions to …
Feb 11, 2021 CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellnessSee details»
CURE Pharmaceutical Announces the Appointment of New Board …
Aug 2, 2022 Gerald Bagg brings deep understanding of CPG to CUREOXNARD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR) (“CURE”), …See details»
CURE Pharmaceutical Receives ISO Certification for Laboratory and ...
May 13, 2021 ISO 9001 certification recognizes excellence in quality management standards of an organization that places an emphasis on its customers, the motivation and implication of …See details»
CURE Pharmaceutical | Psychedelic Invest
CURE Pharmaceutical is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery …See details»
CURE Pharmaceutical Announces the Appointment of New Board
OXNARD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- CURE Pharmaceutical Holding Corp. (OTC: CURR) (“CURE”), a proprietary platform technology company, today announced the …See details»
CURE Pharmaceutical Provided Full Corporate Update on
Aug 9, 2022 Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth …See details»
Cure Pharmaceutical sells drug delivery patents in $20M deal
Aug 2, 2022 Cure Pharmaceutical is cashing in some of its drug delivery intellectual property, selling patents covering film-based drug delivery to TF Tech Ventures in a deal worth $20 …See details»
CURE Pharmaceutical Announces Addition of Two New Clinical …
Mar 10, 2021 CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announSee details»
CURE Pharmaceutical Announces the Sale of a Portion of its
Jul 28, 2022 Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth …See details»
CURE Pharmaceutical Reports Increase in Revenue to $7.7 Million …
Apr 1, 2021 Fiscal Year 2020 Highlights: Generated dramatic growth in total and pro forma revenue Released positive clinical data on its patented drug delivery technology and received …See details»
CURE Pharmaceutical Announces the Sale of a Portion of its …
Jul 28, 2022 Proceeds Will Be Used to Grow CURE’s Wellness and Beauty Brands and Its Remaining Proprietary Platform TechnologyOXNARD, Calif., July 28, 2022 (GLOBE …See details»
CURE Pharmaceutical Announces Positive Findings from Study at ...
May 12, 2022 CURE’s Patented and Proprietary OTF Vitamin D Found to be More Effective than Standard Supplementation in Achieving pre- and post-Surgery Vitamin D Sufficiency …See details»
CURE Pharmaceutical Announces Positive Findings from Study
May 12, 2022 CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children’s Hospital Medical Center (CCHMC) Using CURE’s Proprietary, Oral Thin Film (OTF) …See details»